# Eversight Illinois – FDA Inspection, Jun 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/eversight-illinois/bcb4d369-162e-4484-8bcd-d4a62c2666d9
Source feed: FDA_Inspections

> FDA inspection 1241628 of Eversight Illinois, June 18, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 1271. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1241628
- Company Name: Eversight Illinois
- Inspection Date: 2024-06-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1055320 - 2018-04-18](https://www.keypedia.com/records/fda_inspections/eversight-illinois/581c8d56-785a-472c-89cd-9c2899524865)
- FDA Inspection 968460 - 2016-05-09
- FDA Inspection 883885 - 2014-06-18
- FDA Inspection 759437 - 2011-12-19
- FDA Inspection 634088 - 2009-12-03

## Related Officers

- [Emily S. McGann](https://www.keypedia.com/people/emily-s-mcgann/43891ff3-bd70-4337-b61c-e16cc7ad0468)
- [Issuing Officer](https://www.keypedia.com/people/gabryelle-j-solverud/29c4452f-2f7a-4325-8f8d-7046fcb4690f)

Company: https://www.keypedia.com/companies/eversight-illinois/7b7a3e81-0ca7-4d57-b230-5dc8e929c6a6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
